SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-232049
Filing Date
2017-07-20
Accepted
2017-07-20 16:09:02
Documents
7
Period of Report
2017-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d423160d8k.htm 8-K 24786
2 EX-1.1 d423160dex11.htm EX-1.1 173957
3 EX-5.1 d423160dex51.htm EX-5.1 7330
4 EX-99.1 d423160dex991.htm EX-99.1 7121
5 EX-99.2 d423160dex992.htm EX-99.2 7216
6 GRAPHIC g423160g42j30.gif GRAPHIC 3512
7 GRAPHIC g423160g52p61.gif GRAPHIC 1272
  Complete submission text file 0001193125-17-232049.txt   228369
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 17974459
SIC: 2834 Pharmaceutical Preparations